biofire® filmarray® pneumonia panel Search Results


filmarray pneumonia panel  (BioFire Defense)
90
BioFire Defense filmarray pneumonia panel
Filmarray Pneumonia Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/filmarray pneumonia panel/product/BioFire Defense
Average 90 stars, based on 1 article reviews
filmarray pneumonia panel - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pcr kit biofire filmarray atypical pneumonia panel  (BioFire Defense)
90
BioFire Defense pcr kit biofire filmarray atypical pneumonia panel
Pcr Kit Biofire Filmarray Atypical Pneumonia Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcr kit biofire filmarray atypical pneumonia panel/product/BioFire Defense
Average 90 stars, based on 1 article reviews
pcr kit biofire filmarray atypical pneumonia panel - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
filmarray pneumonia (pn) panel  (BioFire Diagnostics)
90
BioFire Diagnostics filmarray pneumonia (pn) panel
Filmarray Pneumonia (Pn) Panel, supplied by BioFire Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/filmarray pneumonia (pn) panel/product/BioFire Diagnostics
Average 90 stars, based on 1 article reviews
filmarray pneumonia (pn) panel - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
fap plus - filmarray® pneumonia plus panel  (BioFire Defense)
90
BioFire Defense fap plus - filmarray® pneumonia plus panel
Fap Plus Filmarray® Pneumonia Plus Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fap plus - filmarray® pneumonia plus panel/product/BioFire Defense
Average 90 stars, based on 1 article reviews
fap plus - filmarray® pneumonia plus panel - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
broad-panel respiratory mpcr filmarray pneumonia panel plus  (BioFire Defense)
90
BioFire Defense broad-panel respiratory mpcr filmarray pneumonia panel plus
Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results <t>(mPCR</t> FA-PPP, urine antigen assays, blood cultures and Gram stain examination of <t>respiratory</t> tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.
Broad Panel Respiratory Mpcr Filmarray Pneumonia Panel Plus, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/broad-panel respiratory mpcr filmarray pneumonia panel plus/product/BioFire Defense
Average 90 stars, based on 1 article reviews
broad-panel respiratory mpcr filmarray pneumonia panel plus - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
biofire filmarray pneumonia panel  (BioFire Diagnostics)
90
BioFire Diagnostics biofire filmarray pneumonia panel
Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results <t>(mPCR</t> FA-PPP, urine antigen assays, blood cultures and Gram stain examination of <t>respiratory</t> tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.
Biofire Filmarray Pneumonia Panel, supplied by BioFire Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biofire filmarray pneumonia panel/product/BioFire Diagnostics
Average 90 stars, based on 1 article reviews
biofire filmarray pneumonia panel - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
filmarray panel for m. pneumoniae  (BioFire Defense)
90
BioFire Defense filmarray panel for m. pneumoniae
Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results <t>(mPCR</t> FA-PPP, urine antigen assays, blood cultures and Gram stain examination of <t>respiratory</t> tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.
Filmarray Panel For M. Pneumoniae, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/filmarray panel for m. pneumoniae/product/BioFire Defense
Average 90 stars, based on 1 article reviews
filmarray panel for m. pneumoniae - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ctx-m detected by biofire filmarray pneumonia plus panel  (BioFire Defense)
90
BioFire Defense ctx-m detected by biofire filmarray pneumonia plus panel
Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results <t>(mPCR</t> FA-PPP, urine antigen assays, blood cultures and Gram stain examination of <t>respiratory</t> tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.
Ctx M Detected By Biofire Filmarray Pneumonia Plus Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctx-m detected by biofire filmarray pneumonia plus panel/product/BioFire Defense
Average 90 stars, based on 1 article reviews
ctx-m detected by biofire filmarray pneumonia plus panel - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
multiplex polymerase chain reaction amplification of bacterial dna biofire filmarray pneumonia panel [bfpp]  (BioFire Defense)
90
BioFire Defense multiplex polymerase chain reaction amplification of bacterial dna biofire filmarray pneumonia panel [bfpp]
Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results <t>(mPCR</t> FA-PPP, urine antigen assays, blood cultures and Gram stain examination of <t>respiratory</t> tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.
Multiplex Polymerase Chain Reaction Amplification Of Bacterial Dna Biofire Filmarray Pneumonia Panel [Bfpp], supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/multiplex polymerase chain reaction amplification of bacterial dna biofire filmarray pneumonia panel [bfpp]/product/BioFire Defense
Average 90 stars, based on 1 article reviews
multiplex polymerase chain reaction amplification of bacterial dna biofire filmarray pneumonia panel [bfpp] - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results (mPCR FA-PPP, urine antigen assays, blood cultures and Gram stain examination of respiratory tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.

Journal: BMJ Open

Article Title: Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

doi: 10.1136/bmjopen-2020-048187

Figure Lengend Snippet: Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results (mPCR FA-PPP, urine antigen assays, blood cultures and Gram stain examination of respiratory tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.

Article Snippet: In the experimental strategy arm, the microbiological diagnosis combines a broad-panel respiratory mPCR (FilmArray Pneumonia Panel Plus (FA-PPP), BioFire Biomérieux) with conventional microbiological investigations.

Techniques: Staining, Multiplex Assay

Algorithm of early antibiotics de-escalation or discontinuation. The algorithm is applied in the intervention arm only (see red square, ). mPCR, multiplex PCR; ICU, intensive care unit; PCT, procalcitonin.

Journal: BMJ Open

Article Title: Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

doi: 10.1136/bmjopen-2020-048187

Figure Lengend Snippet: Algorithm of early antibiotics de-escalation or discontinuation. The algorithm is applied in the intervention arm only (see red square, ). mPCR, multiplex PCR; ICU, intensive care unit; PCT, procalcitonin.

Article Snippet: In the experimental strategy arm, the microbiological diagnosis combines a broad-panel respiratory mPCR (FilmArray Pneumonia Panel Plus (FA-PPP), BioFire Biomérieux) with conventional microbiological investigations.

Techniques: Multiplex Assay

Primary and secondary outcomes

Journal: BMJ Open

Article Title: Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

doi: 10.1136/bmjopen-2020-048187

Figure Lengend Snippet: Primary and secondary outcomes

Article Snippet: In the experimental strategy arm, the microbiological diagnosis combines a broad-panel respiratory mPCR (FilmArray Pneumonia Panel Plus (FA-PPP), BioFire Biomérieux) with conventional microbiological investigations.

Techniques: Bacteria, Biomarker Discovery